Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression. by Lu Han (151620)

Subjects:

Exclusion and enrollment summary from NHANES. by Lu Han (151620)

Subjects:

Demographic information and baseline population characteristics. by Lu Han (151620)

Subjects:

Stratified associations between systemic inflammation biomarkers and hepatitis C (OR 95%, <i>P</i> value, LOG base 2). by Lu Han (151620)

Subjects:

General addictive models demonstrate the relationship between systemic inflammatory biomarkers and anti-HCV. by Lu Han (151620)

Subjects:

Comparison of systemic inflammation biomarkers in infected and uninfected populations. by Lu Han (151620)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Percentage distribution of maternal deaths by cause of death, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Maternal mortality ratio (MMR) by cause of death, per 100,000 live births, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Comparison of the association between maternal mortality and antenatal care and skilled birth attendance in the last pregnancy; Pakistan 2007 and 2019 (see notes 2, 3). by Farid Midhet (17403945)

Subjects:

MMR (maternal deaths per 100,000 live births) and 95% confidence limits by urban and rural areas, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects: